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Ovarian stimulation is an important tool to increase the number of oocytes obtained by laparoscopy for the in vitro 
production of embryos (IVP). In sheep, different concentrations of FSH administered in single dose (SD) or multiple 
doses (MD) have been adopted. In parallel, the oocyte quality is fundamental for IVP success, so strategies to 
produce more competent oocytes have been evaluated. The aim of this study was to evaluate the gene expression 
profile of BCB+ COC from different hormonal protocols of ovarian stimulation in Santa Inês ewes. To achieve that, 
a cross-over design was used, where 12 pluriparous ewes had their follicular wave synchronized (Balaro et al., 
Domest Anim Endocrinol, 54: 10-14, 2016). At 80 h after progestogen implant removal, all ewes received a new 
vaginal sponge and it started the stimulation by administration of: 80 (Group 1 - 80-SD) or 120 (Group 2 - 120-SD) 
mg FSH (Folltropin-V®, Bioniche Animal Health, Ontario, Canada) and 300 IU of eCG both in single dose, or 80 
(Group 3 - 80-MD) or 120 (Group 4 - 120-MD) in decreasing doses (50/30/20%) every 12 h. The COCs were 
recovered by laparoscopy and classified morphologically in grade I / II (homogeneous ooplasm and more than 3 
cumulus cells layers), III (homogeneous ooplasm and less than 3 cumulus cells layers or partially denuded) and IV 
(heterogeneous ooplasm or degenerate). For inference of the development competence GI, II and III COCs were 
stained with bright cresyl blue (BCB) and classified into: BCB+ (competent) and BCB- (non-competent). These 
variables were compared by ANOVA followed by Tukey test. The abundance of mRNA that encodes proteins 
associated with steroidogenesis (STAR, FSHr, LHr and ERα), oocyte quality (MATER, BMP15, GDF9 and ZAR1) 
and apoptosis (BAX and Bcl-2) was assessed by real-time qPCR normalized with GAPDH in BCB+ COCs. The 
abundance of gene transcripts associated with steroidogenesis was down-regulated (P <0.05) with increasing FSH 
concentration, when administration was performed in a single dose (80-SD and 120-SD). On the other hand, when 
the administration was performed in MD, only the LHr was down-regulated (80-MD and 120-MD). In the 80-MD 
group, FSHr and Erα were down-regulated (P <0.05) in comparison with 80-SD. For genes related with oocyte 
quality, 80-MD showed up-regulation (P <0.05) to MATER (when compared to 80-SD), ZAR1 and MATER 
(compared to 120-SD). Nonetheless, apoptosis genes were not affected. These data demonstrate that the FSH dose 
and strategy of administration affect the gene expression profile in ovine COCs. Subsequent studies are necessary to 
assess the effect of this change on maturation rate and developmental competence. 
